Cargando…

B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents

OBJECTIVES: The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres, Ignacio, Albert, Eliseo, Giménez, Estela, Alcaraz, María Jesús, Botija, Pilar, Amat, Paula, Remigia, María José, Beltrán, María José, Rodado, Celia, Huntley, Dixie, Olea, Beatriz, Navarro, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223011/ https://www.ncbi.nlm.nih.gov/pubmed/34174397 http://dx.doi.org/10.1016/j.cmi.2021.06.013

Ejemplares similares

Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty® COVID-19 vaccine
por: Giménez, Estela, et al.
Publicado: (2022)

Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents
por: Sánchez-Sendra, Beatriz, et al.
Publicado: (2022)

SARS-CoV-2-reactive IFN-γ-producing CD4(+) and CD8(+) T cells in blood do not correlate with clinical severity in unvaccinated critically ill COVID-19 patients
por: Olea, Beatriz, et al.
Publicado: (2022)

Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents
por: Albert, Eliseo, et al.
Publicado: (2022)

SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine
por: Giménez, Estela, et al.
Publicado: (2022)

Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients
por: Olea, Beatriz, et al.
Publicado: (2021)

Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
por: de Michelena, Paula, et al.
Publicado: (2022)

Comparison of two methods skipping cell lysis and protein extraction for identification of bacteria from blood cultures by matrix-assisted laser desorption/ ionization time-of-flight mass-spectrometry
por: Torres, Ignacio, et al.
Publicado: (2019)

Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR
por: Valdivia, Arantxa, et al.
Publicado: (2021)

Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
por: Hein, Sascha, et al.
Publicado: (2021)

A performance comparison of two (electro) chemiluminescence immunoassays for detection and quantitation of serum anti‐spike antibodies according to SARS‐CoV‐2 vaccination and infections status
por: Camacho, Jorge, et al.
Publicado: (2022)

Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking
por: Davó, Laura, et al.
Publicado: (2021)

Revision of Comirnaty precautions in Japan
Publicado: (2022)

mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection
por: Casado, José L., et al.
Publicado: (2023)

No safety concerns with Comirnaty vaccine in pregnancy
Publicado: (2021)

Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients
por: Costa, Rosa, et al.
Publicado: (2022)

Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: May it help to predict clinical outcomes?
por: Forqué, Lorena, et al.
Publicado: (2022)

SARS-CoV-2-Spike Antibody and T-Cell Responses Elicited by a Homologous Third mRNA COVID-19 Dose in Hemodialysis and Kidney Transplant Recipients
por: Panizo, Nayara, et al.
Publicado: (2022)

Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination
por: Tormo, Nuria, et al.
Publicado: (2022)

Comirnaty va enfin affronter le variant Omicron
por: Manus, Jean-Marie
Publicado: (2022)

Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy)
por: Fano, Valeria, et al.
Publicado: (2022)

New insights into antibody levels against SARS-CoV-2 for healthcare personnel vaccinated with tozinameran (Comirnaty)
por: Fernández-Suárez, Antonio, et al.
Publicado: (2022)

The Biofire® Filmarray® Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation
por: Ferrer, Josep, et al.
Publicado: (2023)

Early tolerability of Comirnaty vaccine in patients with chronic neurological diseases
por: Budowski, C., et al.
Publicado: (2021)

Booster son immunité avec Comirnaty : mode d'emploi
por: Manus, Jean-Marie
Publicado: (2021)

Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
por: Tan, Cheng Siang, et al.
Publicado: (2022)

Post-COMIRNATY(Ⓡ) Non-episodic Angioedema with Eosinophilia: An Elderly Case
por: Sato, Yu, et al.
Publicado: (2021)

A neurologist’s rhombencephalitis after comirnaty vaccination. A change of perspective
por: Walter, Alexander, et al.
Publicado: (2021)

Safety update on COVID-19 vaccine Comirnaty finds no new concerns
Publicado: (2021)

Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccine
por: Marcelino, João, et al.
Publicado: (2022)

Rhabdomyolysis after COVID-19 Comirnaty Vaccination: A Case Report
por: Ruijters, Veerle J., et al.
Publicado: (2022)

Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severity
por: Olea, Beatriz, et al.
Publicado: (2021)

Cumulative incidence of SARS‐CoV‐2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
por: Camacho, Jorge, et al.
Publicado: (2022)

Adverse Events to Comirnaty Vaccine Are Linked to Sex, Age and BMI: Should We Consider Reducing the Dose for Females?
por: Azzolini, Elena, et al.
Publicado: (2023)

Effusive–constrictive pericarditis after the second dose of BNT162b2 vaccine (Comirnaty): a case report
por: Viani, Giacomo Maria, et al.
Publicado: (2022)

Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®)
por: Edler, Carolin, et al.
Publicado: (2021)

Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rash
por: Stoyanov, Alex, et al.
Publicado: (2022)

Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination( )
por: Chua, Gilbert T, et al.
Publicado: (2021)

NZ's Medsafe reminder: pericarditis/myocarditis may occur after Comirnaty vaccination
Publicado: (2022)

Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status
por: Helle, François, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rnj3ed6tjr5702ki68ppmen65m